期刊文献+

24例初诊B-CLL的免疫表型分析 被引量:1

B-CLL immune phenotype analysis of 24 cases
暂未订购
导出
摘要 目的:探讨B细胞慢性淋巴细胞白血病(chronic lymphocytic leukemia,CLL)的免疫表型特点。方法:应用流式细胞仪分析24例初诊B-CLL患者外周血或骨髓的免疫表型。结果:24例初诊CLL患者21例CD5+、CD23+最终被确诊为CLL,其余3例分别被诊断为套细胞淋巴瘤(MCL)和滤泡淋巴瘤(FL)。结论:免疫分型对CLL的诊断及鉴别诊断有重要意义,CD38和ZAP70的表达是CLL患者预后的重要指标。 Objective:To investigate the immunophenotypic characteristics of B-cell chronic lymphocytic leukemia(B-CLL).Methods: Flow cytometry was used to analyze the phenotype of peripheral blood or bone marrow from 24 cases who were newly diagnosed as B-CLL.Results:Twenty one out of 24 cases of CLL patients was diagnosed of CLL finally because of CD5^+,CD23^+,the rest cases were diagnosed as mantle cell lymphoma(MCL) and follicular lymphoma(FL).Conclusion: Immunophenotyping was very useful for the diagnosis and differential diagnosis of CLL,and the expression of CD38 and ZAP70 were important prognostic indicators of CLL patients.
出处 《现代肿瘤医学》 CAS 2012年第11期2364-2366,共3页 Journal of Modern Oncology
基金 湖北省自然科学基金(编号:2011CDC105)
关键词 B细胞慢性淋巴细胞白血病 流式细胞术 免疫表型 CD38 ZAP70 B-cell chronic lymphocytic leukemia flow cytometry immunological phenotype CD38 ZAP70
  • 相关文献

参考文献15

  • 1Rossi FM,Del Principe MI,Rossi D. Prognostic impact of ZAP70 expression in chronic lymphocytic leukemia:mean fluorescence intensity T/B ratio versus percentage of positive cells[J].Journal of Traditional Medicines,2010.23.
  • 2张之南;沈悌.血液病诊断及疗效标准[M]北京:科学出版社,2007139-147.
  • 3陈佳宁,王静,赵淑芳,张永宏.慢性淋巴细胞白血病免疫表型分析[J].临床和实验医学杂志,2008,7(11):7-8. 被引量:5
  • 4Lanasa MC,Allgood SD,Slager SL. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2011,(09):1459-1466.
  • 5Lanasa MC,Weinberg JB. Immunologic aspects of monoclonal B-cell lymphocytosis[J].Immunologic Research,2011,(1-3):269-280.
  • 6李增军,吴瞳,邱录贵,李业楠.以淋巴增殖性疾病为表现的套细胞淋巴瘤的临床与诊断分析[J].临床血液学杂志,2009,22(3):225-228. 被引量:8
  • 7易莎,张小斌,陈燕.103例慢性淋巴细胞白血病患者免疫表型的研究[J].临床血液学杂志,2010,23(2):86-88. 被引量:26
  • 8Shanafelt TD. Predicting clinical outcome in CLL:how and why[J].Hematology,2009.421-429.
  • 9Cruse JM,Lewis RE,Webb RN. ZAP70 and CD38 as predictors of IgVH mutation in CLL[J].Experimental and Molecular Pathology,2007,(03):459-461.
  • 10Bazargan A,Tam CS,Keating MJ. Predicting survival in chronic lymphocytic leukemia[J].Expert Review of Anticancer Therapy,2012,(03):393-403.

二级参考文献15

  • 1DECAUDIN D. Mantle cell lymphoma: a biological and therapeutic paradigm[J]. Leuk Lymphoma,2002, 43:773--781.
  • 2VELDERS G A,KLUIN-NELEMANS J C, DE BOER C J, et al. Mantle-cell lymphoma., a population-based clinical study[J]. J Clin Oncol, 1996,14 : 1269 - 1274.
  • 3FERRER A, SALAVERRIA I, BOSCH F, et al. Leukemic involvement is a common feature in mantle cell lymphoma[J]. Cancer,2007,109 :2473--2480.
  • 4COHEN P L,KURTIN P J,DONOVAN K A,et al. Bone marrow and peripheral blood involvement in mantle cell lymphoma[J].Br J Haematol, 1998,101: 302--310.
  • 5MATUTES E, OWUSU-ANKOMAH K, MORILLA R,et al. The immunological profile of B-cell disorders and proposal of a scoringsystem for the diagnosis of CLL[J].Leukemia, 1994,8 : 1640-- 1645.
  • 6MATUTES E,PARRY-JONES N,BRITO-BABAPU LLE V, et al. The leukemic presentation of mantle cell lymphoma:disease features and prognostic factors in 58 patients[J]. Leuk Lymphoma, 2004,45 : 2007 -- 2015.
  • 7VIZCARRA E, MARTINEZ-CLIMENT J A, BENET I,et al. Identification of two subgroups of mantle cell leukemia with distinct elinical and biological features [J]. Hematol J, 2001,2 : 234-- 241.
  • 8INAMDAR K V,BUESO-RAMOS C E.Pathology of chronic lymphocytic leukemia:an update[J].Ann Diagnostic Pathol,2007,11:363-389.
  • 9MATUTES E,POLLIACK A.Morphological and immunophenotypic Features of chronic lymphocytic leukemia[J].Rev Clin Exp Hematol,2000,4:22-47.
  • 10BENE M C,BEMIER M,CASASNOVAS R O,et al.Proposals for the immunological classification of acute leukemia.European Group for the Immunological Characterization of Leukemias (EGIL)[J].Leukemia,1995,9:1783-1786.

共引文献35

同被引文献19

  • 1Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagno- sis and treatment of chronic lymphocytic leukemia : a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute - Working Group 1996 guidelines [ J ]. Blood,2008,111 ( 12 ) :5446 - 5456.
  • 2Ghia P, Hallek M. Management of chronic lymphocytic leukemia [ J ]. Haematologica ,2014,99 (6) :965 - 972.
  • 3Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia[ J]. N Engl J Med ,2000, 343(26) :1910 - 1916.
  • 4Mayr C, Speicher MR, Kofler DM, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia [ J ]. Blood,2006,107 (2) :742 - 751.
  • 5Siegel R,Ma J,Zou Z,et al. Cancer statistics,2014[ J]. CA Cancer J Clin,2014,64( 1 ) :9-29.
  • 6Marti GE, Carter P, Abbasi F, et al. B - cell monoclonal lymphocy- tosis and B - cell abnormalities in the setting of familial B - cell chronic lymphocytic leukemia[ J]. Cytometry B ClinCytom,2003, 52(1) :1 -12.
  • 7Lanasa MC, Allgood SD, Slager SL, et al. Immunophenotypic and gene expression analysis of monoclonal B - cell lymphocytosiss- hows biologic characteristics associated with good prognosis CLL [ J]. Leukemia ,2011,25 (9) : 1459 - 1466.
  • 8Damle RN, Ghiotto F, Valetto A, et al. B - cell chronic lymphocyt- ic leukemia cells express a surface membrane phenotype of activa- ted, antigen - experienced B lymphocytes [ J ]. Blood, 2002,99 ( 11 ) :4087 -4093.
  • 9Dillman RO. Immunophenotyping of chronic lymphoid leukemias [J]. J Clin Oncol,2008,26(8) :1193 - 1194.
  • 10Inamdar KV, Bueso - Ramos CE. Pathology of chronic lymphocytic leukemia : an update [ J ]. Ann DiagnPathol, 2007,11 ( 5 ) : 363 - 389.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部